EVOTEC (UK) LIMITED
Company Information
- Company Number
- 02674265
- Registered Address
- 114 Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
- Status
- Active
- Employee Count
- 512
- Turnover
- £60,605,000
- EBITDA
- £12,878,000
Additional Details
- Website
- https://evotec.com/
- Company Type
- Private limited Company
- Incorporated On
- 19 December 1991
- Nature of Business
- 72110 - Research and experimental development on biotechnology
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 23 Jul 2025 | 32 | 56% | 41% | 3% | 14% |
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 31 | 61% | 36% | 3% | 16% |
| 01 Jan 2024 - 30 Jun 2024 | 30 Jul 2024 | 31 | 62% | 35% | 2% | 19% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 38 | 62% | 27% | 11% | 36% |
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 36 | 60% | 34% | 6% | 27% |
| 01 Jan 2021 - 30 Jun 2021 | 26 Jul 2021 | 38 | 53% | 41% | 5% | 26% |
| 01 Jul 2019 - 31 Dec 2019 | 31 Jan 2020 | 35 | 55% | 41% | 4% | 21% |
| 01 Jul 2018 - 31 Dec 2018 | 24 Jan 2019 | 34 | 60% | 37% | 3% | 21% |
| 01 Jan 2018 - 30 Jun 2018 | 20 Jul 2018 | 37 | 58% | 31% | 11% | 35% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
https://www.evotec.com/uploads/download-files/Terms_And_Conditions/GTCsForPurchase-EvotecUK.pdf
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Dispute Resolution Process
In the event of a dispute, a query can be raised with the accounts payable department via e-mail . This department will work closely with the invoice approver and will strive to achieve resolution in a timely manner.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
EVOTEC (UK) LIMITED is a leading drug discovery and development company based in the United Kingdom. The company was founded in 1993 and has since grown to become a global leader in the pharmaceutical industry.
The company's main focus is on providing innovative and high-quality drug discovery services to its clients in the pharmaceutical and biotechnology sectors. Their services include target identification and validation, hit identification, lead optimization, and preclinical and clinical development. They also offer integrated drug discovery solutions, combining cutting-edge technology and expertise to accelerate the drug discovery process.
EVOTEC (UK) LIMITED is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company has set targets to reduce its carbon footprint and increase the use of renewable energy sources. They also have a recycling program in place and encourage their employees to adopt sustainable practices.
One of the key people at EVOTEC (UK) LIMITED is the Chief Executive Officer, Dr. Werner Lanthaler, who has been with the company since 2009. He has extensive experience in the pharmaceutical industry and is responsible for the overall strategy and direction of the company.
The company's registered office address is located in Abingdon, Oxfordshire, and their website is www.evotec.com. On their website, customers can find information about their services, sustainability program, and news and events. They can also contact the company through their website or by phone or email for any inquiries.
In conclusion, EVOTEC (UK) LIMITED is a leading drug discovery and development company in the UK, with a strong focus on sustainability and providing high-quality services to their clients. With a dedicated team and a commitment to innovation, the company continues to make significant contributions to the pharmaceutical industry.
